Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022

BUY
$6.28 - $15.59 $174,584 - $433,402
27,800 New
27,800 $222,000
Q4 2021

Feb 14, 2022

SELL
$14.7 - $28.67 $405,720 - $791,292
-27,600 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$24.31 - $33.6 $459,459 - $635,040
18,900 Added 217.24%
27,600 $785,000
Q2 2021

Aug 16, 2021

BUY
$26.09 - $40.4 $226,983 - $351,480
8,700 New
8,700 $293,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.